@callmeburty's peptide therapy claims, fact-checked

What did @callmeburty actually say?

The creator claims that topical GHK-Cu (copper peptide) produces "the exact same thing" as injectable peptides for skin texture, acne scarring, and redness, and that six to eight weeks of daily application will deliver comparable results without injections. They also push a specific product and advise buying the larger size for cost efficiency.

To summarize the pitch: skip the needle, use this topical instead, and look for a product that actually contains copper and GHK. That's the core argument. It sounds reasonable on the surface, but the "exact same thing" framing is where this gets complicated fast.

Does the science back this up?

Partially. GHK-Cu does have legitimate skin research behind it, but the claim that topical delivery equals injectable delivery is not supported by current evidence. Absorption is the problem.

GHK-Cu (glycine-histidine-lysine copper complex) has been studied for wound healing, collagen stimulation, and antioxidant activity. Pickart and Margolina (2018, Cosmetics) reviewed decades of GHK-Cu research and found real evidence for fibroblast activation, collagen and glycosaminoglycan synthesis, and anti-inflammatory effects in cell and animal models. That part checks out.

What the research does not confirm is that topical GHK-Cu penetrates deeply enough to replicate systemic or subcutaneous peptide delivery. Peptide skin penetration depends heavily on molecular weight, formulation vehicle, and skin barrier integrity. A 2020 review by Lintner et al. in the International Journal of Cosmetic Science notes that most peptides in topical cosmetic formulations show limited transdermal delivery without specific penetration-enhancing technologies. The creator skips over this entirely.

What did they get wrong (or right)?

They got the baseline biology roughly right. GHK-Cu is not pseudoscience. It has genuine peer-reviewed support for skin-related biological activity, and the idea of starting with a less invasive approach before considering injectables is not unreasonable advice in principle.

What they got wrong is the equivalency claim. Saying topical application does "the exact same thing" as injectable GHK-Cu or related peptides is not accurate. Injectable peptides bypass the skin barrier entirely. Topical products face significant absorption limitations, and no controlled human trial has directly compared topical versus injectable GHK-Cu outcomes for acne scarring or skin texture.

The product recommendation is also a problem. Citing a specific brand without disclosing financial relationships, and advising on sizing and purchasing decisions, edges into territory that a 3-million-view TikTok probably should not be in. There is no independent verification of what is actually in any product they are showing.

• Accurate: GHK-Cu has real evidence for collagen and skin repair activity
• Accurate: Starting non-invasive before considering injectables is a reasonable general framework
• Misleading: "Does the exact same thing" is unsupported by comparative evidence
• Unverifiable: Personal six-week anecdote with no controls or baseline documentation

What should you actually know?

GHK-Cu is one of the better-studied cosmetic peptides. That said, "studied" in cosmetics research often means in vitro (cell culture) or animal models, not large randomized controlled trials in humans. Finkley et al. (1996, Journal of Geriatric Dermatology) showed topical copper peptides improved skin laxity in a small human trial, but sample sizes in this literature are consistently small.

If you are genuinely interested in GHK-Cu for skin concerns, a topical product is a reasonable, lower-risk starting point compared to self-administered injectables sourced from unregulated suppliers. Injectable peptides carry infection risk, dosing risk, and in many jurisdictions require a prescription and medical supervision for good reason.

But manage your expectations. A topical is not the same as subcutaneous delivery. Results described in anecdotal TikTok content are not clinical outcomes. And any peptide product, topical or injectable, should ideally be part of a conversation with a licensed provider who can assess your actual skin concerns.

Bottom line on this video

The creator is not spreading dangerous misinformation, but they are overstating what the evidence actually shows. "The exact same thing" is a claim the science cannot currently support. GHK-Cu topicals have legitimate biological rationale and some human trial data behind them, but no head-to-head comparison with injectable routes exists. The product plug without disclosed affiliation, to an audience of millions, deserves scrutiny regardless of whether the underlying ingredient has merit.